Hancock Jaffe Laboratories (NSDQ:HJLI) announced that it successfully completed a public offering worth $41.1 million. Irvine, Calif.-based Hancock Jaffe sold more than 5.9 million shares of common stock and warrants to purchase nearly 3 million common shares in the offering, according to a news release. The $41.1 million collected in proceeds by the company are earmarked […]
hancockjaffelabs
Hancock Jaffe Labs appoints interim CFO
Hancock Jaffe Laboratories (NSDQ:HJLI) announced last week that it appointed Craig Glynn as interim chief financial officer and interim treasurer. Glynn is a veteran of more than 35 years in financial services, both with public and private companies and in the role of CFO. He founded Edward Thomas Associates in 2012 to provide public and private […]
Hancock Jaffe Labs in danger of losing NASDAQ listing
NASDAQ has warned Hancock Jaffe Laboratories (NSDQ:HJLI) that it is in danger of being delisted, but the company said in an SEC filing today that it intends to return to compliance. The warning, issued last week, said Hancock Jaffe did not have the minimum of $2.5 million in stockholders’ equity to merit its listing on the […]
Hancock Jaffe touts 6-month results for VenoValve
Hancock Jaffe Laboratories (NSDQ:HJLI) said yesterday that six-month data from its in-human VenoValve study showed that the first five patients observed displayed improvements in all study endpoints. Principal investigator Dr. Jorge Hernando Ulloa reported that the patients showed 10% improvement in reflux, 2% improvement in disease manifestations (VCSS scores) and 13% improvements in pain (VAS scores) […]
Hancock Jaffe touts early results of VenoValve study
Hancock Jaffe Laboratories (NSDQ:HJLI) said today that reflux has been reduced to normal levels in four of the first patients to receive its VenoValve device, 90 days after implantation. The VenoValve is a porcine valve designed to be implanted into the femoral or popliteal vein to treat lower limb chronic venous insufficiency from damage to leg […]
Hancock Jaffe launches first-in-human VenoValve study
Hancock Jaffe Laboratories (NSDQ:HJLI) said today that it launched the first-in-human study of its VenoValve device, touting its successful implantation in the first subject in the study. The VenoValve is a porcine valve designed to be implanted into the femoral or popliteal vein to treat lower limb chronic venous insufficiency from damage to leg vein valves after deep […]
Hancock Jaffe sets endpoints for FIH VenoValve study
Hancock Jaffe Laboratories (NSDQ:HJLI) today announced the endpoints for its planned first-in-human study of its VenoValve device. The VenoValve is a porcine valve designed to be implanted into the femoral or popliteal vein to treat lower limb chronic venous insufficiency from damage to leg vein valves after deep vein thrombosis, the Irvine, Calif.-based company said. Endpoints for […]
Colombia clears Hancock Jaffe first-in-human VenoValve trial
Hancock Jaffe Laboratories (NSDQ:HJLI) said today that it won regulatory approval from Colombia’s INVIMA, the country’s FDA equivalent, to launch a first-in-human trial of its VenoValve device. The VenoValve is a porcine valve designed to be implanted into the femoral or popliteal vein to treat lower limb chronic venous insufficiency from damage to leg vein valves after […]
Hancock Jaffe clears Colombian regulatory hurdle for VenoValve trial
Hancock Jaffe Laboratories (NSDQ:HJLI) said today that Colombia’s INVIMA, the country’s FDA equivalent, completed their review of the company’s application for a first-in-human trial of its VenoValve, clearing another hurdle towards launching the study. The VenoValve is a porcine valve designed to be implanted into the femoral or popliteal vein to treat lower limb chronic venous insufficiency […]
Google taps ex-Geisinger CEO Feinberg to lead consolidated Google Health biz | Personnel Moves – November 14, 2018
Google (NSDQ:GOOG) has picked up former Geisinger Health CEO David Feinberg to lead its fragmented health divisions under the Google Health moniker, according to a recent CNBC report. The tech giant had been searching for a head for several months, with artificial intelligence head Jeff Dean heavily involved in the process, according to the report. Other […]
Hancock Jaffe steps closer to launching Colombian VenoValve trial
Hancock Jaffe Laboratories (NSDQ:HJLI) said today it won approval from Colombia’s Medical Research Committee at Fundación Santa Fe de Bogotá to launch a first-in-human trial of its VenoValve bioprosthetic valve. The Irvine, Calif.-based company’s VenoValve is a porcine valve designed to be implanted into the femoral or popliteal vein to treat lower limb chronic venous insufficiency from […]